A Rare Case of Acute Myeloblastc Leukemia With Blast Count Less Than 20% in Bone Marrow

One of the diagnostic criteria for Acute Myeloblastic Leukemia (AML) is the presence of 20% myeloid blasts in peripheral blood or bone marrow. Some cases with recurrent cytogenetic abnormalities also fall in this category with blast cell count less than 20%. Thus, in the presence of these genetic a...

Full description

Bibliographic Details
Main Authors: Pardis Nematollahi, Behnaz Sabaghi, Alireza Moafi
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2019-07-01
Series:Case Reports in Clinical Practice
Subjects:
Online Access:https://crcp.tums.ac.ir/index.php/crcp/article/view/210
Description
Summary:One of the diagnostic criteria for Acute Myeloblastic Leukemia (AML) is the presence of 20% myeloid blasts in peripheral blood or bone marrow. Some cases with recurrent cytogenetic abnormalities also fall in this category with blast cell count less than 20%. Thus, in the presence of these genetic abnormalities, the patients are classified as AML regardless of blast cell count. One of these genetic heterogeneities is t(8; 21) (q22, q22.1) which is more commonly seen in children and young adults. In this study, a 14-year-old boy is reported with a final diagnosis of AML, which was presented with fever and bicytopenia, clinically suspicious for acute leukemia. Laboratory results reported less than 20% blasts in bone marrow aspiration smears but genetic alteration t(8; 21) (q22, q22.1) was detected by molecular exams.
ISSN:2538-2683
2538-2691